Can-Fite BioPharma

+$0.009 (+1.03%) As of 4:35 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CANF and other ETFs, options, and stocks.

About CANF

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602.

CEO
Pnina Fishman
Employees
—
Headquarters
Petach Tikva, HaMerkaz
Founded
1994

CANF Key Statistics

Market cap
24.79M
Price-Earnings ratio
—
Dividend yield
—
Average volume
82.69K
High today
$0.91
Low today
$0.854
Open price
$0.8541
Volume
19.81K
52 Week high
$2.62
52 Week low
$0.78

CANF Earnings

-$0.24
-$0.16
-$0.07
$0.01
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected Jun 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure